These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24103354)

  • 1. Characterization of the enhancing lesions on dynamic contrast enhanced magnetic resonance imaging in patients with interstitial mammoplasty.
    Kim TY; Kim SH; Kang BJ; Kim HS; Cha ES; Kim JY; Song BJ
    Eur J Radiol; 2013 Dec; 82(12):2205-11. PubMed ID: 24103354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.
    Kuhl CK; Schild HH; Morakkabati N
    Radiology; 2005 Sep; 236(3):789-800. PubMed ID: 16118161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.
    Kinkel K; Helbich TH; Esserman LJ; Barclay J; Schwerin EH; Sickles EA; Hylton NM
    AJR Am J Roentgenol; 2000 Jul; 175(1):35-43. PubMed ID: 10882243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-mass-like enhancement on contrast-enhanced breast MR imaging: lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Kubo M; Tokunaga E; Yamamoto H; Honda H
    Eur J Radiol; 2010 Jul; 75(1):e126-32. PubMed ID: 19796900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
    Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
    Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
    Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
    Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses.
    Kim SJ; Morris EA; Liberman L; Ballon DJ; La Trenta LR; Hadar O; Abramson A; Dershaw DD
    AJR Am J Roentgenol; 2001 Sep; 177(3):551-7. PubMed ID: 11517046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
    Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
    Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of breast cancer and correlation with prognostic factors.
    Chang YW; Kwon KH; Choi DL; Lee DW; Lee MH; Lee HK; Yang SB; Kim Y; Seo DY
    Acta Radiol; 2009 Nov; 50(9):990-8. PubMed ID: 19863408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BI-RADS lesion characteristics predict likelihood of malignancy in breast MRI for masses but not for nonmasslike enhancement.
    Gutierrez RL; DeMartini WB; Eby PR; Kurland BF; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Oct; 193(4):994-1000. PubMed ID: 19770321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
    Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA
    Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
    Seely JM; Nguyen ET; Jaffey J
    Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-spatial-resolution MR imaging of focal breast masses: interpretation model based on kinetic and morphological parameters.
    Tozaki M; Igarashi T; Matsushima S; Fukuda K
    Radiat Med; 2005 Feb; 23(1):43-50. PubMed ID: 15786751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.
    Baltzer PA; Benndorf M; Dietzel M; Gajda M; Runnebaum IB; Kaiser WA
    AJR Am J Roentgenol; 2010 Jun; 194(6):1658-63. PubMed ID: 20489110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of BI-RADS-MRI descriptors for differentiation between mucinous carcinoma and fibroadenoma.
    Igarashi T; Ashida H; Morikawa K; Motohashi K; Fukuda K
    Eur J Radiol; 2016 Jun; 85(6):1092-8. PubMed ID: 27161057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
    Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
    Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.